219
Views
0
CrossRef citations to date
0
Altmetric
Critical Care Nephrology and Continuous Kidney Replacement Therapy

Clinical significance of the lactate-to-albumin ratio on prognosis in critically ill patients with acute kidney injury

, ORCID Icon, ORCID Icon, , &
Article: 2350238 | Received 22 Nov 2023, Accepted 27 Apr 2024, Published online: 09 May 2024
 

Abstract

Objective

To explore the relationship between lactate-to-albumin ratio (LAR) at ICU admission and prognosis in critically ill patients with acute kidney injury (AKI).

Methods

A retrospective analysis was conducted. Patients were divided into low (<0.659) LAR and high LAR (≥0.659) groups. Least absolute shrinkage and selection operator regression analysis was conducted to select variables associated with the 30-day prognosis. Cox regression analyses were performed to assess the association between LAR and mortality. Kaplan-Meier curves were plotted to compare cumulative survival rates between high and low LAR groups. Subgroup analysis was employed to assess the stability of the results. ROC curve was used to determine the diagnostic efficacy of LAR on prognosis.

Results

A nonlinear relationship was observed between LAR and the risk of 30-day and 360-day all-cause mortality in AKI patients (p < 0.001). Cox regulation showed that high LAR (≥ 0.659) was an independent risk factor for 30-day and 360-day all-cause mortality in patients with AKI (p < 0.001). The Kaplan-Meier survival curves demonstrated a noteworthy decrease in cumulative survival rates at both 30 and 360 days for the high LAR group in comparison to the low LAR group (p < 0.001). Subgroup analyses demonstrated the stability of the results. ROC curves showed that LAR had a diagnostic advantage when compared with lactate or albumin alone (p < 0.001).

Conclusion

High LAR (≥0.659) at ICU admission was an independent risk factor for both short-term (30-day) and long-term (360-day) all-cause mortality in patients with AKI.

Ethics approval and consent to participate

The database was approved by the Institutional Review Boards of Beth Israel Deaconess Medical Center and the Massachusetts Institute of Technology, and one author of the study was granted access to the database (ID number: 42303155).

Authors’ contributions

Penghui Gao contributed to design the study. Xiaoyun Shi wrote the manuscript. Jianhong Lu processed the data and did the analyses. Lei Zhong, Qikai Shen, Beiping Hu contributed to review and edit the manuscript. All the authors read and approved the final manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data that support the findings of this study were available from the corresponding author upon reasonable request.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.